Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > The Daily Journey Of An Experienced Day Trader

Tags

  • product
  • nikki
  • wondering
  • developing combination
  • developing combination
  • still going

  • Links

  • Why Can't You Be Extraordinary?
  • Tooth Whitening Through the Ages
  • Omega 3's... Fish Oil, and DHA...
  • Top Articles - The Daily Journey Of An Experienced Day Trader

    Wake at 7:30 and place 3 short orders and go back to bed for a couple of hours.

    Wake at 10:00 to find none of my trades have triggered. Confident they will and there's nothing new that takes my fancy, I decide to write up a piece on a seminar attended
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    last night and post it on the TNT thread, the finest non-specific thread on ADVFN.

    My new Skype buddy, who I met at a seminar earlier this year, is wondering where I am and is relieved to see me log in. We discuss our trades and evaluate their merit. T
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    day he is long and I am short but we both agree our trades are sound.

    A stop is hit on AHT - I've been in and out all year but my last trade didn't work. The automatic stop got me out before the worst of the fall, job well done, no tea and toast requir
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ed.

    One of my intended shorts CW. may lose its place in FTSE100. When this gets known my short will surely fly and I flirt with entering the trade before my target price is reached. No, discipline is important; I decide to leave my limit order where it
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    is.

    Today I am watching the AAEX - it's been consolidating at a critical level and I can see an easy short to 383 mark. It low tests but rebounds; I shall wait for an end of day close below my target before entering the trade. A good example of where a
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    limit order wouldn't have worked.

    I notice all my candidate shorts are going up but that doesn't bother me. I'm regretting my BUR and CSR share purchases of yesterday but they were small and I will add if they fall further. Both will do well when thin
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    s recover. Bur is fine given it's XD today.

    My recent M&S share purchase into my SIPP is looking sound. I'm pleased to be back in and Moody have upgraded them. Meanwhile I'm eyeing up my SIPP cash wondering what to do. Today doesn't seem to be the righ
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    t day to decide; it's a do nothing day.

    The phone rings and it's MBNA offering me 6k for 9 months at 0% interest. I have to pay a one-off ?75. They agree to pay it into my current account. Excellent, that frees up the money I need to fund my ISA, savin
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    me 9/12 of 5% in lost interest on the cash.

    The post arrives and my interest statement from ZOPA is there. Zopa is an innovative idea set up by the founders of EGG, which allows people like 'us' to lend and borrow to each other. Now I can complete my
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    tax return...a job for this afternoon methinks.

    Also in the post are two books from global investor bookshop. My name is on the packet but I haven't ordered these books. 'Extraordinary popular delusions' and 'superhobby investing'. I shall enjoy the fo
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    mer and sell the latter on ebay, shame it's got a slightly bent spine. Why they have been sent to me is a mystery.

    I get an email from the chap who's going to give me a lesson on Level 2 - I'm new to level 2 and as chance would have it I met someone a
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    couple of weeks ago who said they would be happy to take me through it. I have IGMarkets level 2 but this chap deems this insufficient so I call ADVFN and plead successfully for a free day. T will take me through it tomorrow and then I guess I will have
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    to fork out for it.

    The cat comes for a cuddle. He's not a lap cat but 2 or three times a day he jumps up for a cuddle and nudges my nose. It's over in an instant.

    I check back on my intended shorts but they are all still going up.

    My short of Glyn o
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    n BB is not looking good but I agree with TNT that Nikki is strong. I decide to buy Nikki and keep Glyn short open, hoping that Nikki will prevail. Either way, I am still confident I picked the winner on day one.

    Time for lunch. My table at my caf? is
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    ccupied, don't these strangers know that it's MY table. Reluctantly I sit at the next table and keep up with my positions on my mobile XDA Mini phone, hooking into an unsecured wireless network under the name of 'monkey_penis'. Who cares. My potential s
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    horts are still going up.

    There's a long trade shaping up on VPC. I'll wait to see several ticks above my entry price; caution is the order of the day. No, I decide instead to put in a limit order which will trigger tomorrow if my price is met. No emot
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    on allowed.

    Email arrives saying Tom Winnifrith says buy Avanti Media. I add it to my TomW watch list and pay it no more attention.

    A pop up box offering level 2 training at ADVFN. It was so poor last time and the room was freezing; think I'll give it
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    a miss.

    Digitallook send me a list of broker recommendations - full of the usual contradictions, delete. Money morning has sent an email asking "are we in a bear market?" I know the answer, not yet. Delete. Digitallook commodities round up shows pigs
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    nd sheep down 5%; I wonder why that might be but I haven't the foggiest idea. The Times has CPW as a hold - in fact I'm waiting to short it when they can't deliver the service they have promised.

    'the naked trader' is buying TEP; it's up 7.5% today...h
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    e's a clever sod.

    The UK is heading for a quiet close and as the US is quiet I decide to turn my attention to my tax return. First I cancel my CW short order...it's looking like a buy for now. My other shorts potentials are good; tomorrow's another day


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/102073/toparticles-The-Daily-Journey-Of-An-Experienced-Day-Trader.html">The Daily Journey Of An Experienced Day Trader</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/102073/toparticles-The-Daily-Journey-Of-An-Experienced-Day-Trader.html]The Daily Journey Of An Experienced Day Trader[/url]

    Related Articles:

    Advertising Fits Hats To A T

    7 Simple Key Principles of Relationship Marketing to Attract Lifetime Customers!

    World Events and Wise Forex Trading

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com